Form 4: Adaptive Biotechnologies Director Acquires Shares and Options

Michael J Pellini, a director of Adaptive Biotechnologies, acquired shares and stock options on March 4, 2024.

Summary

• On March 4, 2024, Michael J Pellini, a director of Adaptive Biotechnologies Corp, acquired 31,328 shares of common stock at $0 and disposed of 54,296 shares.
• Following the transaction, Pellini beneficially owns 54,296 shares.
• Pellini also acquired options to purchase 48,044 shares of common stock at an exercise price of $3.99, exercisable in monthly installments over one year from March 4, 2024, expiring on March 4, 2034.
• Following the transaction, Pellini beneficially owns 48,044 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of insider transactions. The acquisition of shares and options by a director could be interpreted as a slightly positive signal, but it's not definitively bullish.

Positives

• A director increasing their holdings could be seen as a positive signal about their confidence in the company's future.

Industry Context

Form 4 filings are routine disclosures required by the SEC when insiders (officers, directors, or those holding more than 10% of a company's shares) trade in their company's stock. These filings provide transparency to the market regarding insider activity.

Stakeholder Impact

• The transaction could have a minor impact on shareholder sentiment, depending on how the market interprets the director's increased stake in the company.

Key Dates